|
Safety and efficacy of a sucrose-formulated recombinant
factor VIII product for the treatment of previously treated
patients with haemophilia A in China
J. SHI,* Y. ZHAO, J. WU, J. SUN,§ L. WANG– and R. YANG*
*Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical
College, Tianjin, China; Department of Hematology, Peking Union Medical College Hospital, Beijing, China; Department
of Hematology, Anhui Provincial Hospital, Hefei, China; §Department of Hematology, Nanfang Hospital, Nanfang Medical
University, Guangzhou, China; and –Medical Department, Bayer HealthCare Company Limited, Beijing, China
原文下载：rFVIII FS在既往治疗的中国血友病A患者中的安全性和有效性评估
|
